Novo Valuation Surpasses Tesla on Experimental Obesity Drug Data Novo Valuation Surpasses Tesla on Experimental Obesity Drug Data

Novo Nordisk on Thursday surpassed Tesla Inc in market valuation after the maker of the popular weight-loss drug Wegovy announced positive early trial data for a highly...Reuters Health Information
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology Source Type: news